Everett Harris & CO Astrazeneca PLC Transaction History
Everett Harris & CO
- $8 Billion
- Q3 2024
A detailed history of Everett Harris & CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Everett Harris & CO holds 3,002 shares of AZN stock, worth $213,592. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,002
Previous 3,002
-0.0%
Holding current value
$213,592
Previous $234,000
0.43%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,343Shares Held
492MCall Options Held
4.99MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.62 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.03 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.89 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.61 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.25 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $220B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...